TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer
Article in Future Oncology (August 2024)
The most recent citing publications are shown below. View all 92 publications that cite this research output on Dimensions.
Article in Future Oncology (August 2024)
Article in Medical Mycology (August 2024)
Article in Vaccine (July 2024)